Literature DB >> 24814418

Trends in macrolide resistance of respiratory tract pathogens in the paediatric population in Serbia from 2004 to 2009.

V Mijac1, N Opavski1, M Markovic1, I Gajic1, Z Vasiljevic2, T Sipetic3, M Bajcetic4.   

Abstract

We report the first study of macrolide resistance in respiratory tract pathogens in a Serbian paediatric population. It included 5293 Streptococcus pneumoniae, 4297 Streptococcus pyogenes, 2568 Moraxella catarrhalis and 1998 Haemophilus influenzae isolates derived from the respiratory tract and 110 invasive isolates from children aged up to 18 years during 2004-2009. Over the 6-year period, a significant increase (P < 0·01) in macrolide resistance was found in both S. pneumoniae and S. pyogenes that reached 45% and 19%, respectively, in 2009. In the same period, consumption of macrolides increased continually from 2·46 to 5·8 defined daily dose/1000 inhabitants per day. The increase in macrolide resistance in S. pyogenes correlated with consumption of total macrolide and long-acting macrolides (r = 0·879, P = 0·05 and r = 0·922, P = 0·026, respectively). A similar trend was observed in pneumoccoci, although it did not reach statistical significance. The growing problem of macrolide resistance in pneumococci and S. pyogenes in Serbia requires further vigilant surveillance.

Entities:  

Keywords:  Bacterial respiratory tract pathogens; macrolide consumption; macrolide resistance

Mesh:

Substances:

Year:  2014        PMID: 24814418      PMCID: PMC9507058          DOI: 10.1017/S0950268814001125

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  11 in total

Review 1.  Clinical and economic implications of antimicrobial resistance for the management of community-acquired respiratory tract infections.

Authors:  David Nicolau
Journal:  J Antimicrob Chemother       Date:  2002-09       Impact factor: 5.790

2.  Resistance to erythromycin in group A streptococci.

Authors:  H Seppälä; A Nissinen; H Järvinen; S Huovinen; T Henriksson; E Herva; S E Holm; M Jahkola; M L Katila; T Klaukka
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

3.  Distribution of emm types among group A streptococcal isolates from Serbia.

Authors:  V Mijac; L Ranin; M Marković; C Heeg; R R Reinert; N Opavski
Journal:  Clin Microbiol Infect       Date:  2009-06-06       Impact factor: 8.067

4.  European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe.

Authors:  Samuel Coenen; Matus Ferech; Surbhi Malhotra-Kumar; Erik Hendrickx; Carl Suetens; Herman Goossens
Journal:  J Antimicrob Chemother       Date:  2006-05-30       Impact factor: 5.790

Review 5.  Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.

Authors:  Joseph P Lynch; George G Zhanel
Journal:  Curr Opin Pulm Med       Date:  2010-05       Impact factor: 3.155

6.  The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens.

Authors:  M Cizman; M Pokorn; K Seme; A Orazem; M Paragi
Journal:  J Antimicrob Chemother       Date:  2001-04       Impact factor: 5.790

7.  The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections.

Authors:  D Felmingham; R N Grüneberg
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

Review 8.  Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period.

Authors:  J Liñares; C Ardanuy; R Pallares; A Fenoll
Journal:  Clin Microbiol Infect       Date:  2010-02-02       Impact factor: 8.067

9.  Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.

Authors:  Miika Bergman; Solja Huikko; Marja Pihlajamäki; Pekka Laippala; Erkki Palva; Pentti Huovinen; Helena Seppälä
Journal:  Clin Infect Dis       Date:  2004-04-14       Impact factor: 9.079

Review 10.  The antimicrobial resistance profile of Streptococcus pneumoniae.

Authors:  R R Reinert
Journal:  Clin Microbiol Infect       Date:  2009-04       Impact factor: 8.067

View more
  2 in total

1.  Changes in Macrolide Resistance Among Group A Streptococci in Serbia and Clonal Evolution of Resistant Isolates.

Authors:  Ina Gajic; Vera Mijac; Lazar Ranin; Edita Grego; Dusan Kekic; Boris Jegorovic; Aleksandra Smitran; Suncica Popovic; Natasa Opavski
Journal:  Microb Drug Resist       Date:  2018-03-20       Impact factor: 3.431

2.  Antibiotic (Mis)Use in COVID-19 Patients before and after Admission to a Tertiary Hospital in Serbia.

Authors:  Aleksa Despotović; Aleksandra Barać; Teodora Cucanić; Ksenija Cucanić; Goran Stevanović
Journal:  Antibiotics (Basel)       Date:  2022-06-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.